|

REGN7508 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Regeneron Pharmaceuticals2

Indications

  • Cancer-Associated Thrombosis (CAT)1
  • Atrial Fibrillation (AF)1
  • Heart Disease1
  • Lung Cancer1
  • Cancer1

Dothan, Alabama1 trial

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

SEC Clinical Research

Phase 2

Hialeah, Florida1 trial

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

Bioresearch Partner- Hialeah Hospital

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.